Skip to main content

Medication & Treatment

News

Study finds COVID-19 vaccines safe for IBD patients

Posted: June 15 2021

Patients with inflammatory bowel diseases (IBD) do not appear to have increased risk of side effects from the Pfizer or Moderna COVID-19 vaccines, according to a recent Cedars-Sinai study published online and upcoming in print in the American Journal of Gastroenterology. In fact, those being treated with advanced immune-modifying therapies may experience them less often than the general population. IBDs, […]

Read more

News

‘Good’ bacteria show promise for clinical treatment of Crohn’s disease and ulcerative colitis

Posted: June 7 2021

A new study published in Nature Communications demonstrates that a consortium of bacteria designed to complement missing or underrepresented functions in the imbalanced microbiome of inflammatory bowel disease (IBD) patients, prevented and treated chronic immune-mediated colitis in humanized mouse models. The study’s senior author, Balfour Sartor, MD, Midget Distinguished Professor of Medicine, Microbiology and Immunology, Co-Director of the UNC Multidisciplinary […]

Read more

Research

A gut feeling

Scientists link genetic makeup of bacteria in the human gut to several human diseases.

By Jen A. Miller We are truly never alone, not even within our own bodies. Human beings play host to trillions of bacteria, fungi, viruses, and other microorganisms that make up the human microbiome. In recent years, the mix of these resident bacteria, and the presence of specific bacterial species, has been linked to conditions ranging […]

Read more

News

What 2,000-year-old poo says about our gut bugs

Posted: May 19 2021

By science reporter Gemma Conroy Many of us spend more time sitting than moving, and we are more likely to reach for a highly processed snack than a stick of celery.  And it turns out our poo has also changed. A new study has found that our gut bugs are vastly different from those that inhabited our hunter-gatherer […]

Read more

News

‘It’s affected my life in many different ways’

Posted: May 10 2021

By 2022, it’s expected that more than 100,000 people will be living with Crohn’s disease and ulcerative colitis in Australia, according to Crohn’s & Colitis Australia (CCA). As the rate of these inflammatory bowel diseases (IBD) continue to rise, CCA is urging people to share what it’s like to live with these life-long illnesses as […]

Read more

News

PBS listing for Australians with a rare epilepsy condition and ulcerative colitis

Posted: May 10 2021

In a historic first, Australians living with a rare form of epilepsy will have access to a medicinal cannabis drug, which is being listed on Australia’s Pharmaceutical Benefits Scheme (PBS) for the first time. From 1 May 2021, Australians living with Dravet syndrome, will have access to Epidyolex® (cannabidiol), a new treatment used in combination with […]

Read more

Blog

5 Common mistakes that can make ulcerative colitis worse

Posted: May 10 2021

By Meghan Rabbitt When you live with ulcerative colitis (UC), you know that symptoms can return even if you’ve been in remission—and even if you’re doing everything you can to avoid a flare. Yet there are a number of missteps you might not even realize you’re making that can worsen your condition, says Matilda Hagan, M.D., co-director for […]

Read more

Research

Podcast: Perivascular nerve dysfunction in inflammatory bowel disease

What is the effect of vascular function in the pathogenesis of Inflammatory Bowel Disease (IBD)?

Find podcast here. IBD patients are at greater risk for developing cardiovascular disease compared to age-matched peers. Listen as Consulting Editor Camilla Wenceslau (University of Toledo) interviews senior author Erika Boerman (University of Missouri) and expert Pooneh Bagher (Texas A&M Health Science Center) about this novel study by Norton et al. Decreased blood flow to […]

Read more

News

Microbial infection impairs healing in Crohn’s disease

Posted: April 30 2021

The work was led by Dr Thaddeus Stappenbeck, Chair of the Cleveland Clinic Lerner Research Institute’s Department of Inflammation & Immunity, and also included researchers from Washington University in St. Louis, Cedars-Sinai Medical Center and Dartmouth College. Together, they found that levels of the yeast Debaryomyces hansenii — commonly found in cheese and processed meat — are higher in Crohn’s disease patients, particularly abundant […]

Read more

Research

Sarcopenia and vitamin D deficiency in patients with Crohn’s disease: Pathological conditions that should be linked together

Sarcopenia is a prevalent condition in patients with Crohn’s disease (CD), representing an independent predictor factor for the development of major postoperative complications.

Excerpt: Introduction Crohn’s disease (CD) is a chronic and progressive inflammatory bowel disease (IBD) that has a high impact on a patient’s quality of life. It is well known that all segments of the gastrointestinal tract can be affected by CD, mainly the terminal ileum and colon. Inflammation is generally segmental, asymmetrical, and transmural. Although […]

Read more